Φορτώνει......
Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo
PURPOSE: BIBF 1120 is a potent triple angiokinase inhibitor now being evaluated in many types of tumors. We examine the antitumor effects of BIBF 1120 on nasopharyngeal carcinoma (NPC) in vitro and in vivo. MATERIALS AND METHODS: The effect of BIBF 1120 on NPC cell proliferation was evaluated using...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Drug Des Devel Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4801128/ https://ncbi.nlm.nih.gov/pubmed/27042009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S96634 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|